ESR1 and neoplasm: There is evidence that tumor infiltrating Treg cells endowed with immunosuppressive potential are associated with tumor progression and unfavorable prognosis, especially in estrogen receptor (ER)-negative breast cancer (Bates et al. 2006; Kim et al. 2013; Liu et al. 2012a).